Serum uric acid and the risk of hypertension and chronic kidney disease

Current Opinion in Rheumatology

Volumn 26, Issue 2, 2014, Pages 176-185

  Feig, Daniel I ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

chronic kidney disease; clinical trials; epidemiology; hypertension; uric acid

Indexed keywords

ANIMALS; BIOLOGICAL MARKERS; CLINICAL TRIALS AS TOPIC; ENZYME INHIBITORS; HUMANS; HYPERTENSION; HYPERURICEMIA; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; URIC ACID; URICOSURIC AGENTS; XANTHINE OXIDASE;

EID: 84894048021     PISSN: 10408711     EISSN: 15316963     Source Type: Journal    
DOI: 10.1097/BOR.0000000000000033     Document Type: Review

References (107)

1. Mahomed FA. On chronic Bright's disease, and its essential symptoms. Lancet 1879; 1:399-401
2. Haig A. Uric acid as a factor in the causation of disease. 4th ed. London: J & A Churchill; 1897
3. Wu X, Wakamiya M, Vaishnav S, et al. Hyperuricemia and urate nephropathy in urate oxidase-deficient mice. Proc Natl Acad Sci U S A 1994; 91:742-746
4. Mazzali M, Hughes J, Kim YG, et al. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension 2001; 38:1101-1106
5. Mazzali M, Kanellis J, Han L, et al. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol 2002; 282:F991-F997
6. Mazzali M, Kim YG, Suga S, et al. Hyperuricemia exacerbates chronic cyclosporine nephropathy. Transplantation 2001; 71:900-905
7. Sanchez-Lozada LG, Tapia E, Lopez-Molina R, et al. Effects of acute and chronic L-Arginine treatment in experimental hyperuricemia. Am J Physiol Renal Physiol 2007; 292:F1238-F1244
8. Sautin YY, Nakagawa T, Zharikov S, Johnson RJ. Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/ nitrosative stress. Am J Physiol Cell Physiol 2007; 293:C584-C596
9. Gersch MS, Mu W, Cirillo P, et al. Fructose, but not dextrose, accelerates the progression of chronic kidney disease. Am J Physiol Renal Physiol 2007; 293:F1256-F1261
10. Watanabe S, Kang DH, Feng L, et al. Uric acid hominoid evolution and the pathogenesis of salt-sensitivity. Hypertension 2002; 40:355-360
11. Kang DH, Johnson RJ. Uric acid induces C-reactive protein expression via upregulation of angiotensin type I receptor in vascular endothelial and smooth muscle cells. J Am Soc Nephrol 2003; F-PO336
12. Kang DH, Nakagawa T, Feng L, et al. A role for uric acid in the progression of renal disease. J Am Soc Nephrol 2002; 13:2888-2897
13. Kanellis J, Watanabe S, Li JH, et al. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogenactivated protein kinase and cyclooxygenase-2. Hypertension 2003; 41:1287-1293
14. Price K, Sautin Y, Long D, et al. Human vascular smooth muscule cells express a urate transporter. J Am Soc Nephrol 2006; 17:1791-1795
15. Kohagura K, Kochi M, Miyagi T, et al. An association between uric acid levels and renal arteriolopathy in chronic kidney disease: A biopsy-based study. Hypertens Res 2013; 36:43-49
16. Sanchez-Lozada LG, Tapia E, Santamaria J, Herrera-Acosta J. Mild hyperuricemia increases arteiolopathy inducing renal cortical ischemia in 5/6 nephrectomy rats. J Am Soc Nephrol 2003; 13:618A
17. Sanchez-Lozada LG, Tapia E, Bautista-Garcia P, et al. Effects of febuxostat on metabolic and renal alterations in rats with fructose-induced metabolic syndrome. Am J Physiol Renal Physiol 2008; 294:F710-F718
18. Silverstein DM, Srivaths PR, Mattison P, et al. Serum uric acid is associated with high blood pressure in pediatric hemodialysis patients. Pediatr Nephrol 2011; 26:1123-1128
19. Graessler J, Graessler A, Unger S, et al. Association of the human urate transporter 1 with reduced renal uric acid excretion and hyperuricemia in a German Caucasian population. Arthritis Rheum 2006; 54:292-300
20. McArdle PF, Parsa A, Chang YP, et al. Association of a common nonsynonymous variant in GLUT9 with serum uric acid levels in old order amish. Arthritis Rheum 2008; 58:2874-2881
21. Parsa A, Brown E, Weir MR, et al. Genotype-based changes in serum uric acid affect blood pressure. Kidney Int 2012; 81:502-507
22. Cannella AC, Mikuls TR. Understanding treatments for gout. Am J Manag Care 2005; 11:S451-S458
23. Lee JE, Kim YG, Choi YH, et al. Serum uric acid is associated with microalbuminuria in prehypertension. Hypertension 2006; 47:962-967
24. Schlesinger N. Dietary factors and hyperuricaemia. Curr Pharm Des 2005; 11:4133-4138
25. Hwang LC, Tsai CH, Chen TH. Overweight and obesity-related metabolic disorders in hospital employees. J Formos Med Assoc 2006; 105:56-63
26. Reyes AJ. The increase in serum uric acid concentration caused by diuretics might be beneficial in heart failure. Eur J Heart Fail 2005; 7:461-467
27. Rho YH, Zhu Y, Choi HK. The epidemiology of uric acid and fructose. Semin Nephrol 2011; 31:410-419
28. Nakagawa T, Hu H, Zharikov S, et al. A causal role for uric acid in fructoseinduced metabolic syndrome. Am J Physiol Renal Physiol 2006; 290:F625-F631
29. Fox IH, Kelley WN. Studies on the mechanism of fructose-induced hyperuricemia in man. Metabolism 1972; 21:713-721
30. Hwang IS, Ho H, Hoffman BB, Reaven GM. Fructose-induced insulin resistance and hypertension in rats. Hypertension 1987; 10:512-516
31. Brown C, Culloo A, Yepuri G, Montani J. Fructose ingestion acutely elevates blood pressure in healthy young humans. Am J Physiol Regul Integr Comp Physiol 2008; 294:R730-R737
32. Bobridge KS, Haines GL, Mori TA, et al. Dietary fructose in relation to blood pressure and serum uric acid in adolescent boys and girls. J Hum Hypertens 2013; 27:217-224
33. Perez-Pozo SE, Schold J, Nakagawa T, et al. Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: Role of uric acid in the hypertensive response. Int J Obes 2009; 34:454-461
34. Nguyen S, Choi H, Lustig R, Hsu C. The association of sugar sweetened beverage consumption on serum uric acid and blood pressure in a nationally representative sample of adolescents. J Pediatr 2009
35. Kahn HA, Medalie JH, Neufeld HN, et al. The incidence of hypertension and associated factors: The Israel ischemic heart study. Am Heart J 1972; 84:171-182
36. Fessel WJ, Siegelaub AB, Johnson ES. Correlates and consequences of asymptomatic hyperuricemia. Arch Intern Med 1973; 132:44-54
37. Gruskin AB. The adolescent with essential hypertension. Am J Kidney Dis 1985; 6:86-90
38. Rovda Iu I. Uric acid and arterial hypertension. Pediatriia 1992; 10:74-78
39. Brand FN, McGee DL, Kannel WB, et al. Hyperuricemia as a risk factor of coronary heart disease: The Framingham Study. Am J Epidemiol 1985; 121:11-18
40. Torok E, Gyarfas I, Csukas M. Factors associated with stable high blood pressure in adolescents. J Hypertens Suppl 1985; 3 (Suppl 3):S389-S390
41. Selby JV, Friedman GD, Quesenberry CP Jr. Precursors of essential hypertension: Pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries. Am J Epidemiol 1990; 131:1017-1027
42. Hunt SC, Stephenson SH, Hopkins PN, Williams RR. Predictors of an increased risk of future hypertension in Utah. A screening analysis. Hypertension 1991; 17:969-976
43. Goldstein HS, Manowitz P. Relation between serum uric acid and blood pressure in adolescents. Ann Hum Biol 1993; 20:423-431
44. Jossa F, Farinaro E, Panico S, et al. Serum uric acid and hypertension: The Olivetti heart study. J Hum Hypertens 1994; 8:677-681
45. Dyer AR, Liu K, Walsh M, et al. Ten-year incidence of elevated blood pressure and its predictors: The CARDIA study. Coronary Artery Risk Development in (Young) Adults. J Hum Hypertens 1999; 13:13-21
46. Taniguchi Y, Hayashi T, Tsumura K, et al. Serum uric acid and the risk for hypertension and type 2 diabetes in Japanese men. The Osaka Health Survey. J Hypertens 2001; 19:1209-1215
47. Imazu M, Yamamoto H, Toyofuku M, et al. Hyperinsulinemia for the development of hypertension: Data from the Hawaii-Los Angeles-Hiroshima Study. Hypertens Res 2001; 24:531-536
48. Feig DI, Johnson RJ. Hyperuricemia in childhood primary hypertension. Hypertension 2003; 42:247-252
49. Masuo K, Kawaguchi H, Mikami H, et al. Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension 2003; 42:474-480
50. Nakanishi N, Okamato M, Yoshida H, et al. Serum uric acid and the risk for development of hypertension and imparied fasting glucose or type II diabetes in Japanese male office workers. Eur J Epidemiol 2003; 18:523-530
51. Nagahama K, Inoue T, Iseki K, et al. Hyperuricemia as a predictor of hypertension in a screened cohort in Okinawa, Japan. Hypertens Res 2004; 27:835-841
52. Alper AB Jr, Chen W, Yau L, et al. Childhood uric acid predicts adult blood pressure: The Bogalusa Heart Study. Hypertension 2005; 45:34-38
53. Sundstrom J, Sullivan L, Dágostino RB, et al. Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension 2005; 45:28-33
54. Perlstein TS, Gumieniak O, Williams GH, et al. Uric acid and the development of hypertension: The normative aging study. Hypertension 2006; 48:1031-1036
55. Mellen PB, Bleyer AJ, Erlinger TP, et al. Serum uric acid predicts incident hypertension in a biethnic cohort: The atherosclerosis risk in communities study. Hypertension 2006; 48:1037-1042
56. Shankar A, Klein R, Klein BE, Nieto FJ. The association between serum uric acid level and long-Term incidence of hypertension: Population-based cohort study. J Hum Hypertens 2006; 20:937-945
57. Forman JP, Choi H, Curhan GC. Plasma uric acid level and risk for incident hypertension among men. J Am Soc Nephrol 2007; 18:287-292
58. Krishnan E, Kwoh CK, Schumacher HR, Kuller L. Hyperuricemia and incidence of hypertension among men without metabolic syndrome. Hypertension 2007; 49:298-303
59. Forman JP, Choi H, Curhan GC. Uric acid and insulin sensitivity and risk of incident hypertension. Arch Intern Med 2009; 169:155-162
60. Zhang W, Sun K, Yang Y, et al. Plasma uric acid and hypertension in a Chinese community: Prospective study and metaanalysis. Clin Chem 2009; 55:2026-2034
61. Jones DP, Richey PA, Alpert BS. Comparison of ambulatory blood pressure reference standards in children evaluated for hypertension. Blood Press Monit 2009; 14:103-107
62. Leite ML. Uric acid and fibrinogen: Age-modulated relationships with blood pressure components. J Hum Hypertens 2011; 25:476-483
63. Grayson PC, Kim SY, LaValley M, Choi HK. Hyperuricemia and incident hypertension: A systematic review and meta-Analysis. Arthritis Care Res (Hoboken) 2011; 63:102-110
64. Jolly SE, Mete M, Wang H, et al. Uric acid, hypertension, and chronic kidney disease among Alaska Eskimos: The Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN) study. J Clin Hypertens (Greenwich) 2012; 14:71-77
65. Loeffler LF, Navas-Acien A, Brady TM, et al. Uric acid level and elevated blood pressure in US adolescents: National Health and Nutrition Examination Survey. Hypertension 2012; 59:811-817
66. Bao W, Srinivasan SR, Wattigney WA, BerensonGS. Persistence of multiple cardiovascular risk clustering related to syndrome X from childhood to young adulthood. The Bogalusa Heart Study. Arch Intern Med 1994; 154:1842-1847
67. Emokpae AM, Abdu A. Serum uric acid levels among nigerians with essential hypertension. Niger J Physiol Sci 2013; 28:41-44
68. Turak O, Ozcan F, Tok D, et al. Serum uric acid, inflammation, and nondipping circadian pattern in essential hypertension. J Clin Hypertens (Greenwich) 2013; 15:7-13
69. Viazzi F, Antolini L, Giussani M, et al. Serum uric acid and blood pressure in children at cardiovascular risk. Pediatrics 2013; 132:e93-e99
70. Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for cardiovascular disease and death: The Framingham Heart Study. Ann Intern Med 1999; 131:7-13
71. Nefzger MD, Acheson RM, Heyman A. Mortality from stroke among U.S. veterans in Georgia and 5 western states. I. Study plan and death rates. J Chronic Dis 1973; 26:393-404
72. Saito I, Folsom AR, Brancati FL, et al. Nontraditional risk factors for coronary heart disease incidence among persons with diabetes: The Atherosclerosis Risk in Communities (ARIC) Study. Ann Intern Med 2000; 133:81-91
73. Staessen J. The determinants and prognostic significance of serum uric acid in elderly patients of the European Working Party on High Blood Pressure in the Elderly trial. Am J Med 1991; 90:50S-54S
74. Bao X, Wang Q, Chen G, et al. Serum concentration of uric acid associated with prehypertension among chinese population. Angiology 2013. [Epub ahead of print, PMID: 24163122
75. Feig DI, Soletsky B, Johnson RJ. Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: A randomized trial. JAMA 2008; 300:924-932
76. Soletsky B, Feig DI. Uric acid reduction rectifies prehypertension in obese adolescents. Hypertension 2012; 60:1148-1156
77. Song K, Wang Y, Wang G, et al. Does decreasing serum uric acid level prevent hypertension?: A nested RCT in cohort study:rationale, methods, and baseline characteristics of study cohort. BMC Public Health 2013; 13:1069
78. Iseki K, Oshiro S, Tozawa M, et al. Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects. Hypertens Res 2001; 24:691-697
79. Domrongkitchaiporn S, Sritara P, Kitiyakara C, et al. Risk factors for development of decreased kidney function in a southeast Asian population: A 12-year cohort study. J Am Soc Nephrol 2005; 16:791-799
80. Chonchol M, Shlipak MG, Katz R, et al. Relationship of uric acid with progression of kidney disease. Am J Kidney Dis 2007; 50:239-247
81. Obermayr RP, Temml C, Gutjahr G, et al. Elevated uric acid increases the risk for kidney disease. J Am Soc Nephrol 2008; 19:2407-2413
82. Sturm G, Kollerits B, Neyer U, et al. Uric acid as a risk factor for progression of nondiabetic chronic kidney disease? The Mild to Moderate Kidney Disease (MMKD) Study. Exp Gerontol 2008; 43:347-352
83. Weiner DE, Tighiouart H, Elsayed EF, et al. Uric acid and incident kidney disease in the community. J Am Soc Nephrol 2008; 19:1204-1211
84. Borges RL, Hirota AH, Quinto BM, et al. Uric acid as a marker for renal dysfunction in hypertensive women on diuretic and nondiuretic therapy. J Clin Hypertens (Greenwich) 2009; 11:253-259
85. Chen N, Wang W, Huang Y, et al. Community-based study on CKD subjects and the associated risk factors. Nephrol Dial Transplant 2009; 24:2117-2123
86. Chen YC, Su CT, Wang ST, et al. A preliminary investigation of the association between serum uric acid and impaired renal function. Chang Gung Med J 2009; 32:66-71
87. Hsu CY, Iribarren C, McCulloch CE, et al. Risk factors for end-stage renal disease: 25-year follow-up. Arch Intern Med 2009; 169:342-350
88. Madero M, Sarnak MJ, Wang X, et al. Uric acid and long-Term outcomes in CKD. Am J Kidney Dis 2009; 53:796-803
89. Park JT, Kim DK, Chang TI, et al. Uric acid is associated with the rate of residual renal function decline in peritoneal dialysis patients. Nephrol Dial Transplant 2009; 24:3520-3525
90. See LC, Kuo CF, Chuang FH, et al. Serum uric acid is independently associated with metabolic syndrome in subjects with and without a low estimated glomerular filtration rate. J Rheumatol 2009; 36:1691-1698
91. Bellomo G, Venanzi S, Verdura C, et al. Association of uric acid with change in kidney function in healthy normotensive individuals. Am J Kidney Dis 2010; 56:264-272
92. Ben-Dov IZ, Kark JD. Serum uric acid is a GFR-independent long-Term predictor of acute and chronic renal insufficiency: The Jerusalem Lipid Research Clinic cohort study. Nephrol Dial Transplant 2011; 26:2558-2566
93. Dawson J, Jeemon P, Hetherington L, et al. Serum uric acid level, longitudinal blood pressure, renal function, and long-Term mortality in treated hypertensive patients. Hypertension 2013; 62:105-111
94. Helal I, McFann K, Reed B, et al. Serum uric acid, kidney volume and progression in autosomal-dominant polycystic kidney disease. Nephrol Dial Transplant 2013; 28:380-385
95. Iseki K, Iseki C, Kinjo K. Changes in serum uric acid have a reciprocal effect on eGFR change: A 10-year follow-up study of community-based screening in Okinawa, Japan. Hypertens Res 2013; 36:650-654
96. Krishnan E, Akhras KS, Sharma H, et al. Serum urate and incidence of kidney disease among veterans with gout. J Rheumatol 2013; 40:1166-1172
97. Oh CM, Park SK, Ryoo JH. Serum uric acid level is associated with the development of microalbuminuria in Korean men. Eur J Clin Invest 2014; 44:4-12
98. Ohta Y, Tsuchihashi T, Kiyohara K, Oniki H. Increased uric acid promotes decline of the renal function in hypertensive patients: A 10-year observational study. Intern Med 2013; 52:1467-1472
99. Neal DA, Tom BD, Gimson AE, et al. Hyperuricemia, gout, and renal function after liver transplantation. Transplantation 2001; 72:1689-1691
100. Fairbanks LD, Cameron JS, Venkat-Raman G, et al. Early treatment with allopurinol in familial juvenile hyerpuricaemic nephropathy (FJHN) ameliorates the long-Term progression of renal disease. QJM 2002; 95:597-607
101. Siu YP, Leung KT, Tong MK, Kwan TH. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Dis 2006; 47:51-59
102. Kanbay M, Ozkara A, Selcoki Y, et al. Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearence, and proteinuria in patients with normal renal functions. Int Urol Nephrol 2007; 39:1227-1233
103. Goicoechea M, de Vinuesa SG, Verdalles U, et al. Effect of allopurinol in chronic kidney disease progression and cardiovascular risk. Clin J Am Soc Nephrol 2010; 5:1388-1393
104. Momeni A, Shahidi S, Seirafian S, et al. Effect of allopurinol in decreasing proteinuria in type 2 diabetic patients. Iran J Kidney Dis 2010; 4:128-132
105. Kao MP, Ang DS, Gandy SJ, et al. Allopurinol benefits left ventricular mass and endothelial dysfunction in chronic kidney disease. J Am Soc Nephrol 2011; 22:1382-1389
106. Kanbay M, Afsar B, Covic A. Uric acid as a cardiometabolic risk factor: To be or not to be. Contrib Nephrol 2011; 171:62-67
107. Pai BH, Swarnalatha G, Ram R, Dakshinamurty KV. Allopurinol for prevention of progression of kidney disease with hyperuricemia. Indian J Nephrol 2013; 23:280-286